The visual electrophysiology market is anticipated to flourish at a steady CAGR of 7.0% between 2023 and 2033. The market is expected to hold a market share of US$ 458.9 million by 2033 while the market is likely to reach a value of US$ 234.1 million in 2023.
New technology, materials, and techniques to produce innovative practice solutions significantly contribute to global market growth. In addition to this, the ease of handling visual electrophysiology devices is surging its adoption in home and alternate care settings.
There is spreading awareness of the requirement for occasional eye examinations for early diagnosis of visual disorders. Therefore retinal electrophysiology is expected to surge the demand for visual electrophysiology.
The market size is expected to increase due to the device’s portability and frequent technological advances. The versatility of visual electrophysiology devices for use on adults, children, or animals of all sizes for clinical and research purposes propels its demand.
| Attributes | Details |
|---|---|
| Visual Electrophysiology Market CAGR (2023 to 2033) | 7.0% |
| Visual Electrophysiology Market Size (2023) | US$ 234.1 million |
| Visual Electrophysiology Market Size (2033) | US$ 458.9 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising technological developments and increasing investments in visual electrophysiology devices are expected to boost market growth. Furthermore, the increasing geriatric population in various parts of the world surges the demand for visual electrophysiology.
Rising expenditures in healthcare advancements and growing adoption practice for visual electrophysiology diagnosis are likely to expand the market size. Moreover, the rising prevalence of neurological and eye disorders are key factors that drive the market growth.
Influx funding for research studies, government initiatives, and awareness programs are growing awareness of the benefits of visual electrophysiology. Additionally, using an electroretinogram (ERG) to eliminate any ophthalmic diseases and establishing correct diagnoses are likely to drive the visual electrophysiology adoption trends.
High costs associated with the diagnosis and treatment procedures, along with the lack of experience in using advanced technologies, pose a threat to this market. Moreover, rigid regulations by the government for recording electrical signals in the electrophysiological test are further expected to hinder market growth.
The absence of skilled professionals and the availability of property healthcare infrastructure in developing economies might hamper the visual electrophysiology market.
Principal Consultant
Growing awareness about the adverse effects of visual and neurological disorders is likely to generate revenue opportunities for the market. Furthermore, increasing research and development (R&D) activities, and technological developments, are expected to accelerate market growth.
Modernization in healthcare devices creates significant opportunities for the market. Additionally, the increasing funding by various governments worldwide is expected to provide growth opportunities. It is important to note that authorities across the world are conducting awareness programs regarding such kinds of tests. This is expected to change the visual electrophysiology market outlook.
| Countries | Revenue Share % (2022) |
|---|---|
| The United States | 33.4% |
| Germany | 5.3% |
| Japan | 3.9% |
| North America | 36.1% |
| Europe | 25.9% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 8.4% |
| India | 7.1% |
| The United Kingdom | 5.4% |
| Australia | 5.7% |
North America holds a notable share of the visual electrophysiology market with a significant revenue of 33%. During the forecast period, the market share is anticipated to expand. This is because of the increasing investments being made in research and development in the region.
There have been increasing cases of eye-related disorders in the region, which is expected to surge the market growth of visual electrophysiology further. Moreover, the ability to be used across age groups is expected to drive this market.
Europe’s visual electrophysiology market held a market share of 25.9% in 2022. Increasing cases of cancer in the region are expected to fuel the growth of the market. Moreover, the rapid advancements in technology are expected to further the rise of this market.
The government in this region is proactive when it comes to dealing with the physical well-being of the population. Therefore, awareness programs are expected to shape the visual electrophysiology market trends in the region.
Asia Pacific is a growing visual electrophysiology market. Improvement of healthcare facilities and economic conditions are likely to surge the market growth.
Japan is also likely to hold a significant market share, owing to the presence of a technologically developed structure. The growing awareness about the importance of eye health is anticipated to bolster the visual electrophysiology market share, in this region. In Asia Pacific as well, increasing investments are being made in research and development, which is expected to drive the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | By Test Type |
|---|---|
| Leading Segment | Electroretinogram (ERG) |
| Market Share% (2022) | 38.80% |
| Category | By Modality |
|---|---|
| Leading Segment | Fixed |
| Market Share% (2022) | 65.90% |
Based on test type, the electroretinogram segment leads the market as it held a market share of 38.80% in 2022. On the other side, the modality category is led by the fixed type segment due to the high consumption. The segment held a market share of 65.90% in 2022.
The ability to locate problems at the early stage and to eliminate specific conditions are increasing the popularity of visual electrophysiology. The startups are offering training to cover recent information on new technology, materials, and techniques for innovative practice solutions. Moreover, certain start-up companies are using traditional methods combined with substantial research and development (R&D) activities. For example,
How is the Competitive Landscape in the Visual Electrophysiology Market?
The extensive range of applications including diagnosis, elimination of specific conditions, locating problems at some level of the visual system, etc. is driving key players to improve devices for visual electrophysiology. This is done through research and development (R&D) activities, for clinical and research purposes.
Recent Developments
Key Region:
The market in China is expected to record a CAGR of 8.4% through 2033.
Abbott, Biosense Webster Inc., Biotronik are the prominent market players.
The industry is forecast to record a CAGR of 7.0% through 2033.
The industry is expected to reach US$ 458.9 million by 2033.
Europe’s visual electrophysiology market held a market share of 25.9% in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033
5.3.1. Electroretinogram (ERG)
5.3.2. Multifocal Electroretinogram (mfERG)
5.3.3. Electro-Oculogram (EOG)
5.3.4. Visual-Evoked Responses (VER)
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Modality, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality, 2023 to 2033
6.3.1. Fixed
6.3.2. Portable
6.4. Y-o-Y Growth Trend Analysis By Modality, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Ambulatory Surgical Centers
7.3.4. Diagnostic Imaging Centers
7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Test Type
9.2.3. By Modality
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.3.3. By Modality
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Test Type
10.2.3. By Modality
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Modality
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Test Type
11.2.3. By Modality
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.3.3. By Modality
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Test Type
12.2.3. By Modality
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Type
12.3.3. By Modality
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Test Type
13.2.3. By Modality
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test Type
13.3.3. By Modality
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Test Type
14.2.3. By Modality
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test Type
14.3.3. By Modality
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Test Type
15.2.3. By Modality
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Test Type
15.3.3. By Modality
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Test Type
16.1.2.2. By Modality
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Test Type
16.2.2.2. By Modality
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Test Type
16.3.2.2. By Modality
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Test Type
16.4.2.2. By Modality
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Test Type
16.5.2.2. By Modality
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Test Type
16.6.2.2. By Modality
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Test Type
16.7.2.2. By Modality
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Test Type
16.8.2.2. By Modality
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Test Type
16.9.2.2. By Modality
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Test Type
16.10.2.2. By Modality
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Test Type
16.11.2.2. By Modality
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Test Type
16.12.2.2. By Modality
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Test Type
16.13.2.2. By Modality
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Test Type
16.14.2.2. By Modality
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Test Type
16.15.2.2. By Modality
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Test Type
16.16.2.2. By Modality
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Test Type
16.17.2.2. By Modality
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Test Type
16.18.2.2. By Modality
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Test Type
16.19.2.2. By Modality
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Test Type
16.20.2.2. By Modality
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Test Type
16.21.2.2. By Modality
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Test Type
16.22.2.2. By Modality
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Test Type
16.23.2.2. By Modality
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Test Type
17.3.3. By Modality
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Metrovision
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Konan Medical USA
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Diopsys Inc
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Nationwide Children’s Hospital
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. The Royal College of Ophthalmologists
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. LKC Technologies Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Boston Scientific Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Abbott
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Biosense Webster Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Biotronik
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. General Electric Company
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Siemens Healthcare GmbH
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. MicroPort Scientific Corporation
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Koninklijke Philips N.V.
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. NIHON KOHDEN CORPORATION
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.16. CardioFocus
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.17. Stereotaxis Inc.
18.1.17.1. Overview
18.1.17.2. Product Portfolio
18.1.17.3. Profitability by Market Segments
18.1.17.4. Sales Footprint
18.1.17.5. Strategy Overview
18.1.17.5.1. Marketing Strategy
18.1.18. Molecular Devices LLC
18.1.18.1. Overview
18.1.18.2. Product Portfolio
18.1.18.3. Profitability by Market Segments
18.1.18.4. Sales Footprint
18.1.18.5. Strategy Overview
18.1.18.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Visual Electrophysiology Market
